Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.
Facon T, Venner CP, Bahlis NJ, Offner F, White DJ, Karlin L, Benboubker L, Rigaudeau S, Rodon P, Voog E, Yoon SS, Suzuki K, Shibayama H, Zhang X, Twumasi-Ankrah P, Yung G, Rifkin RM, Moreau P, Lonial S, Kumar SK, Richardson PG, Rajkumar SV. Facon T, et al. Among authors: yung g. Blood. 2021 Jul 1;137(26):3616-3628. doi: 10.1182/blood.2020008787. Blood. 2021. PMID: 33763699 Free PMC article. Clinical Trial.
Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1.
Garderet L, Laubach JP, Stoppa AM, Hari P, Cavo M, Ludwig H, Mateos MV, Luptakova K, Lin J, Yung G, van de Velde H, Berg D, Moreau P, Richardson PG. Garderet L, et al. Among authors: yung g. Leukemia. 2018 Sep;32(9):2032-2036. doi: 10.1038/s41375-018-0091-3. Epub 2018 Mar 12. Leukemia. 2018. PMID: 29568098 Free PMC article. No abstract available.
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.
Degtyarev E, Rufibach K, Shentu Y, Yung G, Casey M, Englert S, Liu F, Liu Y, Sailer O, Siegel J, Sun S, Tang R, Zhou J; Industry Working Group on Estimands in Oncology. Degtyarev E, et al. Among authors: yung g. Stat Biopharm Res. 2020 Jul 14;12(4):427-437. doi: 10.1080/19466315.2020.1785543. Stat Biopharm Res. 2020. PMID: 34191975 Free PMC article.
Estimands for overall survival in clinical trials with treatment switching in oncology.
Manitz J, Kan-Dobrosky N, Buchner H, Casadebaig ML, Degtyarev E, Dey J, Haddad V, Jie F, Martin E, Mo M, Rufibach K, Shentu Y, Stalbovskaya V, Sammi Tang R, Yung G, Zhou J. Manitz J, et al. Among authors: yung g. Pharm Stat. 2022 Jan;21(1):150-162. doi: 10.1002/pst.2158. Epub 2021 Oct 3. Pharm Stat. 2022. PMID: 34605168
Considerations for master protocols using external controls.
Chen J, Li XN, Lu CC, Yuan S, Yung G, Ye J, Tian H, Lin J. Chen J, et al. Among authors: yung g. J Biopharm Stat. 2024 Feb 16:1-23. doi: 10.1080/10543406.2024.2311248. Online ahead of print. J Biopharm Stat. 2024. PMID: 38363805
79 results